Michael Zinda, EVP, CHIEF SCIENTIFIC OFFICER at Repare Therapeutics Inc. (RPTX), sold 1,350 shares at $4.61 ($6K) on 2024-03-26, disclosed to the SEC on 2024-03-27.
Scheduled sale ($6k) by EVP, CHIEF SCIENTIFIC OFFICER under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $4.78 | 450 | $2K | 34.1% |
| 2 | $4.61 | 450 | $2K | 32.9% |
| 3 | $4.62 | 450 | $2K | 33.0% |
| Total | $4.67 avg | 1,350 | $6K | 100% |
| Filing → |
| RPTX | SELL | 2023-06-09 | $189K | — | Filing → |
| RPTX | SELL | 2023-06-07 | $14K | — | Filing → |
| RPTX | SELL | 2022-03-16 | $6K | — | Filing → |